According to the National Cancer Institute, the US witnessed 15.5 million new cases of cancer in 2016, with approximately USD 147.3 billion spent on cancer care. The institute predicts that the number of new cancer cases per year in the US will rise to 23.6 million by 2030. Canada also faced a significant impact, with an estimated 206,200 new cases of cancer and 80,800 deaths in 2017, according to the Canadian Cancer Society.
In the UK, over 65.3% of total cancers in adults aged 65 years were reported in 2016 by the Office for National Statistics. The Cancer Research UK highlighted that the four most common cancers worldwide are lung, female breast, bowel, and prostate cancer. The increasing prevalence of cancer, coupled with lifestyle factors like higher alcohol and tobacco consumption, rising smoking rates, and poor dietary habits, is fueling the global chemotherapy market.
As more people are diagnosed with cancer, there is a growing need for effective treatments, and chemotherapy plays a crucial role in combating the disease. The market for chemotherapy drugs is driven by the rising demand for these treatments to address the global surge in cancer cases. This demand is further fueled by factors such as an aging population, which is more susceptible to cancer, and lifestyle choices that contribute to the development of the disease.
The financial burden of cancer care is also significant. The substantial amount spent on cancer care in the US, as mentioned earlier, reflects the economic impact of the disease. The costs associated with cancer diagnosis, treatment, and care are substantial, creating a substantial market for chemotherapy drugs and related therapies.
In addition to the economic implications, the emotional and social impact of cancer cannot be overlooked. The increasing prevalence of cancer affects individuals, families, and communities globally. Therefore, the chemotherapy market is not only responding to the medical needs of cancer patients but also addressing the broader challenges associated with the increasing burden of this disease on society.
In conclusion, the rising prevalence of cancer worldwide, coupled with lifestyle factors contributing to its growth, is driving the global chemotherapy market. The economic, emotional, and social impact of cancer underscores the importance of effective treatments, making chemotherapy a crucial component in the fight against this widespread and challenging disease.
Covered Aspects:Report Attribute/Metric | Details |
---|---|
Market Opportunities | Entering developing economies |
Market Dynamics | Increasing prevalence of cancer |
ยฉ 2025 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)